ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2018

Abstract Number: 28

The Rho Kinase Family Member, ROCK2, Promotes Germinal Center Responses and Is Required for Optimal Humoral Immunity

Edd Ricker1, Chao Ye2, Danny Flores-Castro2, Sanjay Gupta3, Michela Manni1, Yurii Chinenov4, Tania Pannellini2, James K. Liao5 and Alessandra B. Pernis6, 1Autoimmunity and Inflammation Program, Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, New York, NY, 3Autoimmunity & Inflammation Research Program, Hospital for Special Surgery, New York, NY, 4Arthritis & Tissue Degeneration Program, Hospital for Special Surgery, New York, NY, 5Cardiology Section, University of Chicago Medical Center, Chicago, IL, 6David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2018

Keywords: B cells and immune activation

Session Information

Date: Sunday, October 21, 2018

Title: B Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Rho GTPases, such as RhoA, are emerging as important regulators of lymphocyte biology owing to their ability to be rapidly activated downstream of a broad range of signals. Two of the major effectors of RhoA signaling are the Rho Kinases (ROCKs), ROCK1 and ROCK2, a pair of serine-threonine kinases that have been previously implicated in the control of cell adhesion, migration, proliferation/survival, and gene expression. Despite the fundamental reliance of T and B cells on these processes, the precise involvement of the ROCKs in lymphocyte biology is yet to be elucidated. Our laboratory previously identified a role for ROCK2 in the differentiation of TH17 cells through the phosphorylation of IRF4. This ROCK2-pIRF4 pathway drives the production of key effector cytokines, such as IL-21, and is deregulated in several autoimmune models. While previous studies have focused on the role of ROCK2 in the T cell compartment, ROCK2 is expressed in other immune cell types, including B cells, leading us to hypothesize that ROCK2 may play a broad role in immunoregulation and T-B collaborations.

Methods: To assess the role of B-cell ROCK2 in T cell-dependent responses, WT mice or mice with B cell-specific deletion of ROCK2 were immunized with a T-dependent antigen and differentiation of germinal center (GC) B cells and plasmablasts/plasma cells (PB/PCs) was monitored by FACS. The molecular mechanisms employed by ROCK2 to promote B cell differentiation was further examined by FACS-sorting B cell populations from spleens of immunized mice followed by qPCR and immunoblot analyses. Total and antigen-specific antibody responses were assessed by ELISA.

Results: We found that ROCK2 is activated in GC B cells and in PB/PCs following immunization and that ROCK2 activity is also induced in vitro upon stimulation with T-cell derived signals such as aCD40 and IL-21. Mice with B cell-specific deletion of ROCK2 exhibited no abnormalities in their mature B cell compartments at baseline, yet showed marked decreases in total and antigen-specific antibody titers in response to immunization with a TD antigen. These decreased humoral responses corresponded with diminished germinal center formation and maintenance following antigen challenge. Residual germinal centers in ROCK2-deficient mice revealed skewed frequencies of GC subpopulations, reduced proliferation, and attenuated class switching to IgG1.

Conclusion: Our study demonstrates that ROCK2 is activated in B cells following immunization with a TD antigen and is required for optimal GC maintenance and function. These findings thus uncover a previously unknown B cell-intrinsic role for ROCK2 in promoting humoral responses and further support the notion that targeting ROCK2 activity may provide therapeutic benefit for the treatment of diseases marked by aberrant B cell responses.


Disclosure: E. Ricker, None; C. Ye, None; D. Flores-Castro, None; S. Gupta, None; M. Manni, None; Y. Chinenov, None; T. Pannellini, None; J. K. Liao, None; A. B. Pernis, None.

To cite this abstract in AMA style:

Ricker E, Ye C, Flores-Castro D, Gupta S, Manni M, Chinenov Y, Pannellini T, Liao JK, Pernis AB. The Rho Kinase Family Member, ROCK2, Promotes Germinal Center Responses and Is Required for Optimal Humoral Immunity [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/the-rho-kinase-family-member-rock2-promotes-germinal-center-responses-and-is-required-for-optimal-humoral-immunity/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-rho-kinase-family-member-rock2-promotes-germinal-center-responses-and-is-required-for-optimal-humoral-immunity/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology